The 4th Antibody Drug Development and Bioprocess Technology Forum

Conference background:

In recent years, antibody drugs and antibody-based therapeutic drugs have gradually become the most important biological products and have entered a golden period of development.

Meeting information:

Conference Time: October 26-27, 2021

Main topics of the conference:

Antibody Drug Development Forum 2021

-The latest development trend of therapeutic antibodies and biological products

Biotechnology Forum 2021

-Frontier bioprocess technology, innovation and production strategy

Some early confirmed speeches/host guests (marked with'+' on the right indicates that this speaker will give a remote speech)

Agenda overview:

Conference registration:

-Chinese domestic unit-

* Biopharmaceutical units refer to companies engaged in the research, development and manufacturing of biological products (internal product development pipelines are required)

Limited free registration [limited to specific unit types and positions]

This conference adopts the real-name registration system, and responds to biopharmaceutical research and development units (including internal product development pipelines), regulatory units, engaged in antibody drug/therapeutic biological product research, product development and project management, analysis and characterization science, and biology Process research, production and quality control, and other related professionals provide limited free participation places.

Notes for filling:

-The number of free places is limited.

* Please note that the organizing committee will check the relevance and applicability based on the information submitted, and reserve the right to accept or reject your free registration application.

Call for posters (registered guests enjoy this right for free)

This forum will provide poster presentation opportunities to promote the application of your company’s latest products, technologies and services in antibody drug development, characterization and analysis technology, process development, and production quality control.

Conference cooperation and contact

The organizing committee is committed to tailoring a suitable participation plan according to the needs of the partners

For agenda and more information, please contact:

Conference speech, content and cooperation

Manager Zhang Wei Zhang

Participation, exhibition display and support opportunities

(Unit initials AN)

(Unit initials OZ) Manager

Media Cooperation

About us:
Diyi Consulting is an information consulting and branded conference operating unit focusing on and serving the Asia-Pacific biopharmaceutical and life science fields.
We focus on the latest regulatory requirements, industry development trends, scientific discoveries and technological updates; through and leading International industry associations, government regulatory agencies, academic and biopharmaceutical industry key opinion leaders and consultants, establish long-term and close cooperation and contacts, we plan and promote influential and branded international conferences, forums, public training and Related consulting services, mainly covering early drug discovery, clinical research, antibody drugs, vaccine products, cell and gene therapy products, bioprocess development, etc.
For more information, please visit: style="vertical-align: inherit;"> .

Deliver Life Sciences is a specialty producer and organizer of the conference, workshop, training together with tailored solutions to serve the growing biomedical industry in Asia.
Through looking into the current trends regulation, scientific findings and cutting-edge technology and work with leading associations , regulatory agency, industry and academia KOLs, we translate, formulate and promote our offerings from basic medicinal research, discovery to development till commercialization.
Our current programs cover Drug Discovery, Clinical Development, Antibody Therapeutics, Vaccines, Cell and Gene Therapies, BioProcess Development .
For more information, please visit: style="vertical-align: inherit;"> .